Mindray Medical announced that it will acquire a controlling stake in Hangzhou Optcla Medical Instrument, a medical device company specializing in endoscope and related surgical instruments. The endoscope market is a rapidly growing segment of the surgical instrument market in China, growing at three times the rate of the global market, according the company. This agreement is indicative of Mindray’s interest to further expand from its base of ultrasound equipment. More details…

Stock symbol: (NYSE: MR)

Share this with colleagues: